Website
https://symbiosis.vc
Industry
6630 Fund management
Business classification
Venture Capital

VCID: 17605215
Profile

Corporate information


Registration country
Investment activity status
Active investor

Company type

Biotech venture capital firm.

Selected investments

Country Date Notes
Metsera Inc
Developer of medicines for obesity and metabolic diseases. 		United States 13 Nov 2024 Series B
Follow-on investment. Round participant. Active

DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.